MedTrace Logo

Observational Investigation of the CDED in a Real World IBD Clinic

NCT05554445 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-10-12

No results posted yet for this study

Summary

A prospective observational study, which will follow a cohort of adult CD patients who are prescribed the Crohn disease exclusion diet (CDED) during their routine clinical dietary therapy. The diet is composed of three phases, at the end of the first two phases we will evaluate whether the patient achieved remission and at the end of phase three the maintenance of remission. We intend to study achievement and remission rate in association to the diet adaptations made by dieticians at phase 1 and 2, together with patient's choice off food at the third phase under real world clinical setting and patient lifestyle characteristics.

Conditions

  • Crohn Disease

Sponsors & Collaborators

  • Eli Sprecher, MD

    lead OTHER_GOV

Principal Investigators

  • Nitsan Maharshak, MD · Tel Aviv Medical Center- Head of Inflammatory Bowel Disease Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-21
Primary Completion
2024-01-01
Completion
2024-12-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05554445 on ClinicalTrials.gov